Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3592.92%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 41.46Close
$ 15.59 - $ 44.46 52-Week Range
Ticker Information
Ticker
CGONCompany Name
CG ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCG ONCOLOGY INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CGON - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 551K | $ 19.8M | 3592.92% |
| 3/31/2025 | $ 662K | $ 15.04M | 2271.3% |
| 12/31/2024 | $ 1.14M | $ 11.4M | 1001.05% |
| 9/30/2024 | $ 684K | $ 7.19M | 1051.17% |
| 12/31/2023 | $ 204K | $ 1.53M | 749.02% |
| 12/31/2022 | $ 191K | $ 676K | 353.93% |
Key Performance Insights, Last 5 Years
- CG ONCOLOGY INC's latest trailing twelve months (TTM) SB Comp % stands at 353.93%.
- Over the past 5 years, CG ONCOLOGY INC's average SB Comp % has been 1503.23%.
- The median SB Comp % for CG ONCOLOGY INC during this period was 1026.11%
- CG ONCOLOGY INC reached its highest SB Comp % over the past 5 years at 3592.92%.
- The lowest SB Comp % recorded by CG ONCOLOGY INC in the same timeframe 353.93%
CG ONCOLOGY INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for CG ONCOLOGY INC is calculated as follows: SB Comp. [ $ 676K ] / Revenues [ $ 191K ]
(=) SB Comp % [ 353.93% ] CGON - Stock Based Compensation Margin, Last 5 years
353.93%
Minimum
Dec 31, 2022
3592.92%
Maximum
Jun 30, 2025
1503.23%
Average
1026.11%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.99K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |